Xenocor Pharmalab Private Limited
About Xenocor Pharmalab Private Limited
Data last updated:
Xenocor Pharmalab Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 13 March 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U29299KA2007PTC042079. Its GSTIN is 29AALCS1972R1ZB (Karnataka).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It was formerly known as Spill Containment Specialities Private Limited. It is led by directors Ranganathaiah Chetan and Niranjana Poojari Chandappa.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2024, the company reported a revenue of ₹8.98 Cr, a growth of 75% compared to the previous year. For the same year it recorded a net profit of ₹16.42 Lakh (net margin 1.8%) and EBITDA of ₹24.38 Lakh (EBITDA margin 2.7%). Revenue has declined at a compounded annual rate (CAGR) of 54% over three years and 2% over five years.
Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Xenocor Pharmalab Private Limited's registered office is in Bangalore, Karnataka. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressNo.33 Rab Complex 18th Main Road 15th Cross 100 Feet Ring Road Jp Nagar, II Phase, Bangalore, Karnataka, India – 560078
- IndustryPharma, API Manufacturers
To see the full contact details of Xenocor Pharmalab Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Xenocor Pharmalab is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Xenocor Pharmalab Private Limited, buy the company report.
Financials of Xenocor Pharmalab Private Limited
FY 2025 filings availableXenocor Pharmalab Private Limited reported revenue of ₹8.98 Cr (up 75% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 75% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 2%. EBITDA rose 45% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹24.38 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹16.42 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.7% | ||||
| Net Profit Margin | 1.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Xenocor Pharmalab Private Limited, buy the company report.
Board of directors of Xenocor Pharmalab Private Limited
Xenocor Pharmalab has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ranganathaiah Chetan | Director | 16 Mar 2023 | 3 Years 7 Months | Current |
| Niranjana Poojari Chandappa | Director | 28 Mar 2022 | 4 Years 7 Months | Current |
Peer comparison
Xenocor Pharmalab Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Omkrown Pharam-Chem Private Limited | ₹9.22 Cr (FY 2025) | 6.0% | Nagar, Shahapur, Belgaum, Karnataka, India | |||
| Shreegen Pharma Limited | ₹9.2 Cr (FY 2023) | -32.0% | Hyderabad, Telangana, India | |||
| Proventus Life Sciences Private Limited | ₹9.17 Cr (FY 2024) | -47.0% | Chennai, Tamil Nadu, India | |||
| Thexa Pharma Private Limited | ₹9.03 Cr (FY 2018) | -84.0% | Madgul, Telangana, India | |||
| Xenocor Pharmalab Private Limitedthis company | ₹8.98 Cr (FY 2024) | ₹16.42 Lakh | 1.8% | 75.0% | Bangalore, Karnataka, India | |
| Aptra Synthesis Private Limited | ₹8.84 Cr (FY 2024) | -24.0% | Hyderabad, Telangana, India | |||
| Chiral Drugs Pvt Ltd | ₹8.77 Cr (FY 2024) | -35.0% | Surat, Gujarat, India |
To see the full peer comparison of Xenocor Pharmalab Private Limited, buy the company report.
Shareholding
The shareholding of Xenocor Pharmalab Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Xenocor Pharmalab Private Limited, buy the company report.
Legal cases
Xenocor Pharmalab Private Limited has 1 court case on record: 1 filed against it. All case is pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| NCLT | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLT, NCLT Bengaluru | Insolvency matter | Filed against the company by an individual | Pending |
To see the full case history of Xenocor Pharmalab Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Xenocor Pharmalab Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Xenocor Pharmalab has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AALCS1972R1ZB | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Xenocor Pharmalab Private Limited, buy the company report.
Recent activity
Xenocor Pharmalab Private Limited has 8 board changes on record since 2010: 2 appointments and 6 cessations. The latest: Ranganathaiah Chetan ceased to be Additional Director on 29 Sep 2023.
Frequently asked questions
Xenocor Pharmalab is an active private limited company based in Bangalore, Karnataka, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 13 March 2007 (19+ years old) and is registered under CIN U29299KA2007PTC042079.
Xenocor Pharmalab has 2 current directors:
- Ranganathaiah Chetan - Director
- Niranjana Poojari Chandappa - Director
The latest financial statements of Xenocor Pharmalab on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Xenocor Pharmalab is 29AALCS1972R1ZB, registered in Karnataka.
The CIN (Corporate Identification Number) of Xenocor Pharmalab is U29299KA2007PTC042079. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Xenocor Pharmalab has 1 court case on record: 1 filed against it. 1 is pending.
Xenocor Pharmalab was incorporated on 13 March 2007, making it 19+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Xenocor Pharmalab by revenue are Omkrown Pharam-Chem Private Limited, Shreegen Pharma Limited, Proventus Life Sciences Private Limited, Thexa Pharma Private Limited, Aptra Synthesis Private Limited and 1 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ranganathaiah Chetan ceased to be Additional Director on 29 Sep 2023. Shejil Balakrishnan ceased to be Director on 21 May 2023. Ranganathaiah Chetan was appointed as Director on 16 Mar 2023. Xenocor Pharmalab has 8 board changes on record in total.
The registered office of Xenocor Pharmalab is at No.33 Rab Complex 18th Main Road 15th Cross 100 Feet Ring Road Jp Nagar, II Phase, Bangalore, Karnataka, India – 560078.
Xenocor Pharmalab operates in the pharma industry, in the api manufacturers segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
